BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Azevedo LS, Pierrotti LC, Abdala E, Costa SF, Strabelli TM, Campos SV, Ramos JF, Latif AZ, Litvinov N, Maluf NZ, Caiaffa Filho HH, Pannuti CS, Lopes MH, Santos VA, Linardi Cda C, Yasuda MA, Marques HH. Cytomegalovirus infection in transplant recipients. Clinics (Sao Paulo). 2015;70:515-523. [PMID: 26222822 DOI: 10.6061/clinics/2015(07)09] [Cited by in Crossref: 96] [Cited by in F6Publishing: 81] [Article Influence: 13.7] [Reference Citation Analysis]
Number Citing Articles
1 Savassi-Ribas F, Gomes Dos Santos de Almeida S, Baez CF, Magalhães de Souza L, Wagner TCS, Matuck TA, Monteiro de Carvalho DB, Marandino Guimarães MAA, Varella RB. Impact assessment and investigation of factors associated with herpesviruses viremia in the first year of renal transplantation. J Med Virol 2020;92:107-12. [PMID: 31463932 DOI: 10.1002/jmv.25580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Moayedi Y, Gomez CA, Fan CPS, Miller RJH, Bunce PE, Tremblay-Gravel M, Foroutan F, Manlhiot C, Yee J, Shullo MA, Khush KK, Ross HJ, Montoya JG, Teuteberg JJ. Infectious complications after heart transplantation in patients screened with gene expression profiling. J Heart Lung Transplant 2019;38:611-8. [PMID: 30704838 DOI: 10.1016/j.healun.2019.01.006] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Forrest C, Gomes A, Reeves M, Male V. NK Cell Memory to Cytomegalovirus: Implications for Vaccine Development. Vaccines (Basel) 2020;8:E394. [PMID: 32698362 DOI: 10.3390/vaccines8030394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Czarnecka P, Czarnecka K, Tronina O, Durlik M. Cytomegalovirus Disease After Liver Transplant-A Description of a Treatment-Resistant Case: A Case Report and Literature Review. Transplant Proc. 2018;50:4015-4022. [PMID: 30577306 DOI: 10.1016/j.transproceed.2018.05.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Dhal U, Raju S, Singh AD, Mehta AC. "For your eyes only": ophthalmic complications following lung transplantation. J Thorac Dis 2018;10:6285-97. [PMID: 30622804 DOI: 10.21037/jtd.2018.09.156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Modvig L, Boyle C, Randall K, Borg A. Severe Cytomegalovirus Reactivation in Patient with Low-Grade Non-Hodgkin's Lymphoma after Standard Chemotherapy. Case Rep Hematol 2017;2017:5762525. [PMID: 29201472 DOI: 10.1155/2017/5762525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
7 Anderson-Smits C, Baker ER, Hirji I. Coinfection rates and clinical outcome data for cytomegalovirus and Epstein-Barr virus in post-transplant patients: A systematic review of the literature. Transpl Infect Dis 2020;22:e13396. [PMID: 32603496 DOI: 10.1111/tid.13396] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
8 Dangi A, Yu S, Luo X. Apoptotic cell-based therapies for promoting transplantation tolerance. Curr Opin Organ Transplant 2018;23:552-8. [PMID: 30024416 DOI: 10.1097/MOT.0000000000000562] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 King MW, Munger J. Editing the human cytomegalovirus genome with the CRISPR/Cas9 system. Virology 2019;529:186-94. [PMID: 30716580 DOI: 10.1016/j.virol.2019.01.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
10 Multani EK, Bajwa D, Multani PK, Nobakht E, Raj D, Paul RS, Paul RS. EYE DISEASE IN KIDNEY TRANSPLANTATION: CLINICAL CHALLENGES IN A UNIQUE PATIENT POPULATION. Surv Ophthalmol 2021:S0039-6257(21)00226-5. [PMID: 34954092 DOI: 10.1016/j.survophthal.2021.12.007] [Reference Citation Analysis]
11 Wagner-Drouet E, Teschner D, Wolschke C, Janson D, Schäfer-Eckart K, Gärtner J, Mielke S, Schreder M, Kobbe G, Kondakci M, Hilgendorf I, von Lilienfeld-Toal M, Klein S, Heidenreich D, Kreil S, Verbeek M, Grass S, Ditschkowski M, Gromke T, Koch M, Lindemann M, Hünig T, Schmidt T, Rascle A, Guldan H, Barabas S, Deml L, Wagner R, Wolff D. Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation. Haematologica 2021;106:363-74. [PMID: 31879324 DOI: 10.3324/haematol.2019.229252] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
12 Jeong S, Lee HS, Kong SG, Kim DJ, Lee S, Park MJ, Song W, Rim JH, Kim HJ. Incidence of malignancy and related mortality after kidney transplantation: a nationwide, population-based cohort study in Korea. Sci Rep 2020;10:21398. [PMID: 33293655 DOI: 10.1038/s41598-020-78283-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Song IH, Ilic K, Murphy J, Lasseter K, Martin P. Effects of Maribavir on P-Glycoprotein and CYP2D6 in Healthy Volunteers. J Clin Pharmacol 2020;60:96-106. [PMID: 31385617 DOI: 10.1002/jcph.1504] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Gniadek TJ, Bachowski G, Gorlin J, Roback JD, Ness PM. Cytomegalovirus-safe blood: the unclear effect of sickle hemoglobin. Transfusion 2017;57:1582-3. [PMID: 28594144 DOI: 10.1111/trf.14138] [Reference Citation Analysis]
15 Arcangeletti MC, Vasile Simone R, Rodighiero I, De Conto F, Medici MC, Maccari C, Chezzi C, Calderaro A. Human cytomegalovirus reactivation from latency: validation of a "switch" model in vitro. Virol J 2016;13:179. [PMID: 27770817 DOI: 10.1186/s12985-016-0634-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
16 Gliga S, Fiedler M, Dornieden T, Achterfeld A, Paul A, Horn PA, Herzer K, Lindemann M. Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients. Vaccines (Basel) 2021;9:88. [PMID: 33504093 DOI: 10.3390/vaccines9020088] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Solovyeva SE, Paltseva EM, Morozova MM, Kaabak MM, Krainik NA, Matveev AV. [Clinical and morphological signs of viral damage to a kidney transplant]. Arkh Patol 2017;79:22-8. [PMID: 28418354 DOI: 10.17116/patol201779222-28] [Reference Citation Analysis]
18 Lindemann M, Wilde B, Friebus-Kardash J, Gäckler A, Witzke O, Dittmer U, Horn PA, Kribben A, Mülling N, Eisenberger U. Comparison of Humoral and Cellular CMV Immunity in Patients Awaiting Kidney Transplantation. Diagnostics (Basel) 2021;11:1688. [PMID: 34574029 DOI: 10.3390/diagnostics11091688] [Reference Citation Analysis]
19 Payandeh M, Zamanian MH, Nomanpour B, Farhadi MS, Janbakhsh A, Rostamian M, Elahi A, Jafari S, Dehghannejad M. Survey of HCMV in allogenic and autologous stem cell transplantation by real-time PCR in Kermanshah, west of Iran. Infect Agent Cancer 2021;16:8. [PMID: 33531035 DOI: 10.1186/s13027-021-00349-4] [Reference Citation Analysis]
20 Yokose T, Obara H, Shinoda M, Nakano Y, Kitago M, Yagi H, Abe Y, Yamada Y, Matsubara K, Oshima G, Hori S, Ibuki S, Higashi H, Masuda Y, Hayashi M, Mori T, Kawaida M, Fujimura T, Hoshino K, Kameyama K, Kuroda T, Kitagawa Y. Colon perforation due to antigenemia-negative cytomegalovirus gastroenteritis after liver transplantation: A case report and review of literature. World J Gastroenterol 2019; 25(15): 1899-1906 [PMID: 31057303 DOI: 10.3748/wjg.v25.i15.1899] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Turner DL, Korneev DV, Purdy JG, de Marco A, Mathias RA. The host exosome pathway underpins biogenesis of the human cytomegalovirus virion. Elife 2020;9:e58288. [PMID: 32910773 DOI: 10.7554/eLife.58288] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Hussein ITM, Brooks J, Bowlin TL. The discovery and development of filociclovir for the prevention and treatment of human cytomegalovirus-related disease. Antiviral Res 2020;176:104710. [PMID: 31940473 DOI: 10.1016/j.antiviral.2020.104710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
23 Keil T, Liu D, Lloyd M, Coombs W, Moffat J, Visalli R. DNA Encapsidation and Capsid Assembly Are Underexploited Antiviral Targets for the Treatment of Herpesviruses. Front Microbiol 2020;11:1862. [PMID: 32903425 DOI: 10.3389/fmicb.2020.01862] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
24 Bellizzi A, Ahye N, Jalagadugula G, Wollebo HS. A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System. J Neuroimmune Pharmacol 2019;14:578-94. [PMID: 31512166 DOI: 10.1007/s11481-019-09878-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Alonso-Guallart P, Duran-Struuck R, Zitsman JS, Sameroff S, Pereira M, Stern J, Berglund E, Llore N, Pierre G, Lopes E, Kofman SB, Danton M, Sondermeijer HP, Woodland D, Kato Y, Ekanayake-Alper DK, Iuga AC, Wuu CS, Wu A, Lipkin WI, Tokarz R, Sykes M, Griesemer A. Impact of CMV Reactivation, Treatment Approaches, and Immune Reconstitution in a Nonmyeloablative Tolerance Induction Protocol in Cynomolgus Macaques. Transplantation 2020;104:270-9. [PMID: 31385931 DOI: 10.1097/TP.0000000000002893] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Aziz F, Jorgenson MR, Parajuli S, Zhong W, Hidalgo LG, Djamali A, Mandelbrot D, Odorico J, Sollinger H, Astor BC, Mohamed MA. Polyomavirus and cytomegalovirus infections are risk factors for grafts loss in simultaneous pancreas and kidney transplant. Transpl Infect Dis 2020;22:e13272. [PMID: 32112710 DOI: 10.1111/tid.13272] [Reference Citation Analysis]
27 Patrucco F, Gavelli F, Ravanini P, Daverio M, Statti G, Castello LM, Andreoni S, Balbo PE. Use of an innovative and non-invasive device for virologic sampling of cough aerosols in patients with community and hospital acquired pneumonia: a pilot study. J Breath Res 2019;13:021001. [PMID: 30523983 DOI: 10.1088/1752-7163/aaf010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
28 Yue C, Kang Z, Ai K, Xu D, Wu J, Pan Y, Yan J, Liu M, Liu Q. Virus infection facilitates the development of severe pneumonia in transplant patients with hematologic malignancies. Oncotarget 2016;7:53930-40. [PMID: 27340772 DOI: 10.18632/oncotarget.10182] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
29 Witzke O, Nitschke M, Bartels M, Wolters H, Wolf G, Reinke P, Hauser IA, Alshuth U, Kliem V. Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: Long-term Results After 7 Years of a Randomized Clinical Trial. Transplantation 2018;102:876-82. [PMID: 29166336 DOI: 10.1097/TP.0000000000002024] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 11.3] [Reference Citation Analysis]
30 Varghese J, Subramanian S, Reddy MS, Shanmugam N, Balajee G, Srinivasan V, Venkataraman J, Mohamed R. Seroprevalence of cytomegalovirus in donors & opportunistic viral infections in liver transplant recipients. Indian J Med Res 2017;145:558-62. [PMID: 28862190 DOI: 10.4103/ijmr.IJMR_1024_14] [Reference Citation Analysis]
31 Nagarakanti S, Bishburg E, Bapat A. Adenovirus, herpes simplex virus and cytomegalovirus infection in a lung transplant recipient. IDCases 2018;11:91-3. [PMID: 29552490 DOI: 10.1016/j.idcr.2018.01.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Alsumali A, Chemaly RF, Graham J, Jiang Y, Merchant S, Miles L, Schelfhout J, Yang J, Tang Y. Cost-effectiveness analysis of cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplant recipients from a US payer perspective. J Med Virol 2021;93:3786-94. [PMID: 32844453 DOI: 10.1002/jmv.26462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Nelson CS, Baraniak I, Lilleri D, Reeves MB, Griffiths PD, Permar SR. Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease. J Infect Dis 2020;221:S45-59. [PMID: 32134477 DOI: 10.1093/infdis/jiz428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
34 Chinta P, Garcia EC, Tajuddin KH, Akhidenor N, Davis A, Faure L, Spencer JV. Control of Cytokines in Latent Cytomegalovirus Infection. Pathogens 2020;9:E858. [PMID: 33096622 DOI: 10.3390/pathogens9100858] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Glotz D, Russ G, Rostaing L, Legendre C, Tufveson G, Chadban S, Grinyó J, Mamode N, Rigotti P, Couzi L, Büchler M, Sandrini S, Dain B, Garfield M, Ogawa M, Richard T, Marks WH; C10-002 Study Group. Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies. Am J Transplant 2019;19:2865-75. [PMID: 31012541 DOI: 10.1111/ajt.15397] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
36 Almaghrabi RS, Omrani AS, Memish ZA. Cytomegalovirus infection in lung transplant recipients. Expert Rev Respir Med 2017;11:377-83. [PMID: 28388307 DOI: 10.1080/17476348.2017.1317596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
37 Tu CC, O'Connor CM, Spencer JV. Identification of a novel signaling complex containing host chemokine receptor CXCR4, Interleukin-10 receptor, and human cytomegalovirus US27. Virology 2020;548:49-58. [PMID: 32838946 DOI: 10.1016/j.virol.2020.06.006] [Reference Citation Analysis]
38 Al Mana H, Yassine HM, Younes NN, Al-Mohannadi A, Al-Sadeq DW, Alhababi D, Nasser EA, Nasrallah GK. The Current Status of Cytomegalovirus (CMV) Prevalence in the MENA Region: A Systematic Review. Pathogens 2019;8:E213. [PMID: 31683687 DOI: 10.3390/pathogens8040213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
39 Alvarado-Esquivel C, Terrones-Saldivar MDC, Hernandez-Tinoco J, Munoz-Terrones MDE, Gallegos-Gonzalez RO, Sanchez-Anguiano LF, Reyes-Robles ME, Antuna-Salcido EI. Seroepidemiology of Cytomegalovirus Infection in Pregnant Women in the Central Mexican City of Aguascalientes. J Clin Med Res 2018;10:337-44. [PMID: 29511423 DOI: 10.14740/jocmr3358w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Kato K, Cooper M. Small bowel perforation secondary to CMV-positive terminal ileitis postrenal transplant. BMJ Case Rep 2019;12:e231662. [PMID: 31772132 DOI: 10.1136/bcr-2019-231662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
41 Ye X, Ku Z, Zhang N, Fu TM, An Z. Recent progress in development of monoclonal antibodies against human cytomegalovirus. Curr Opin Virol 2021;52:166-73. [PMID: 34952264 DOI: 10.1016/j.coviro.2021.12.002] [Reference Citation Analysis]
42 Verma Y, Gupta E, Kumar N, Hasnain N, Bhadoria AS, Pamecha V, Khanna R. Earlier and higher rates of cytomegalovirus infection in pediatric liver transplant recipients as compared to adults: An observational study. J Lab Physicians. 2018;10:221-225. [PMID: 29692591 DOI: 10.4103/jlp.jlp_140_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Rahimishahmirzadi M, Jevnikar AM, House AA, Luke PP, Humar A, Silverman MS, Shalhoub SM, Hosseini-Moghaddam SM. Late-onset allograft rejection, cytomegalovirus infection, and renal allograft loss: Is anti-CMV prophylaxis required following late-onset allograft rejection? Clin Transplant 2021;35:e14285. [PMID: 33713374 DOI: 10.1111/ctr.14285] [Reference Citation Analysis]
44 Combs JA, Norton EB, Saifudeen ZR, Bentrup KHZ, Katakam PV, Morris CA, Myers L, Kaur A, Sullivan DE, Zwezdaryk KJ. Human Cytomegalovirus Alters Host Cell Mitochondrial Function during Acute Infection. J Virol 2020;94:e01183-19. [PMID: 31694945 DOI: 10.1128/JVI.01183-19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
45 Benjanuwattra J, Pruksakorn D, Koonrungsesomboon N. Mycophenolic Acid and Its Pharmacokinetic Drug‐Drug Interactions in Humans: Review of the Evidence and Clinical Implications. The Journal of Clinical Pharmacology 2020;60:295-311. [DOI: 10.1002/jcph.1565] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
46 Pearston AP, Ingemi AI, Ripley K, Wilson TJ, Gruber J, McMahon M, Sutton S, Khardori N. Successful Treatment of UL97 Mutation Ganciclovir-Resistant Cytomegalovirus Viremia in a Renal Transplant Recipient With Letermovir and Adjunct Hyperimmune Cytomegalovirus Immunoglobulin: A Case Report. Transplant Proc 2021;53:1284-7. [PMID: 33715819 DOI: 10.1016/j.transproceed.2021.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
47 DeFreitas MR, McAdams HP, Azfar Ali H, Iranmanesh AM, Chalian H. Complications of Lung Transplantation: Update on Imaging Manifestations and Management. Radiol Cardiothorac Imaging 2021;3:e190252. [PMID: 34505059 DOI: 10.1148/ryct.2021190252] [Reference Citation Analysis]
48 Xue F, Gao W, Qin T, Wu C, Luo Y, Chen J, Zhou T, Feng M, Qiu B, Zhu J, He J, Xia Q. Immune cell function assays in the diagnosis of infection in pediatric liver transplantation: an open-labeled, two center prospective cohort study. Transl Pediatr 2021;10:333-43. [PMID: 33708519 DOI: 10.21037/tp-20-256] [Reference Citation Analysis]
49 Pereira MS, Wagner VP, Munerato MC, Clausell NO, Goldraich LA, Martins MAT, Martins MD, Carrard VC. Chronic painful oral ulcers in a heart transplant recipient. Oral Surg Oral Med Oral Pathol Oral Radiol 2019;127:468-76. [PMID: 29555363 DOI: 10.1016/j.oooo.2018.01.026] [Reference Citation Analysis]
50 Hess NR, Hickey GW, Sultan I, Kilic A. Extracorporeal membrane oxygenation bridge to heart transplant: Trends following the allocation change. J Card Surg 2021;36:40-7. [DOI: 10.1111/jocs.15118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Dangi A, Yu S, Lee FT, Burnette M, Wang JJ, Kanwar YS, Zhang ZJ, Abecassis M, Thorp EB, Luo X. Murine cytomegalovirus dissemination but not reactivation in donor-positive/recipient-negative allogeneic kidney transplantation can be effectively prevented by transplant immune tolerance. Kidney Int 2020;98:147-58. [PMID: 32471635 DOI: 10.1016/j.kint.2020.01.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
52 Almanan M, Raynor J, Sholl A, Wang M, Chougnet C, Cardin RD, Hildeman DA. Tissue-specific control of latent CMV reactivation by regulatory T cells. PLoS Pathog 2017;13:e1006507. [PMID: 28796839 DOI: 10.1371/journal.ppat.1006507] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
53 Gatz JD, Spangler R. Evaluation of the Renal Transplant Recipient in the Emergency Department. Emerg Med Clin North Am 2019;37:679-705. [PMID: 31563202 DOI: 10.1016/j.emc.2019.07.008] [Reference Citation Analysis]
54 Schelfhout J, Brown H, House JA, Raval AD. Cytomegalovirus infection and associated hospitalization and costs among individuals undergoing allogeneic hematopoietic stem cell transplant. Curr Med Res Opin 2020;36:43-50. [PMID: 31490097 DOI: 10.1080/03007995.2019.1664827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Coppock GM, Blumberg E. New treatments for cytomegalovirus in transplant patients. Curr Opin Nephrol Hypertens 2019;28:587-92. [PMID: 31589191 DOI: 10.1097/MNH.0000000000000547] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Ye X, Su H, Wrapp D, Freed DC, Li F, Yuan Z, Tang A, Li L, Ku Z, Xiong W, Jaijyan D, Zhu H, Wang D, McLellan JS, Zhang N, Fu TM, An Z. Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step. PLoS Pathog 2020;16:e1008736. [PMID: 32745149 DOI: 10.1371/journal.ppat.1008736] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
57 Olbrich L, Stockdale L, Basu Roy R, Song R, Cicin-Sain L, Whittaker E, Prendergast AJ, Fletcher H, Seddon JA. Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward. PLoS Pathog 2021;17:e1010061. [PMID: 34882748 DOI: 10.1371/journal.ppat.1010061] [Reference Citation Analysis]
58 Rosenzweig M, Wall A, Spak CW, Testa G, Johannesson L. Pregnancy after CMV infection following uterus transplantation: A case report from the Dallas Uterus Transplant Study. Transpl Infect Dis 2021;23:e13653. [PMID: 34038016 DOI: 10.1111/tid.13653] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
59 Tu CC, Arnolds KL, O'Connor CM, Spencer JV. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms. J Virol 2018;92:e01981-17. [PMID: 29237840 DOI: 10.1128/JVI.01981-17] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
60 Svrlanska A, Ruhland A, Marschall M, Reuter N, Stamminger T. Wedelolactone inhibits human cytomegalovirus replication by targeting distinct steps of the viral replication cycle. Antiviral Res 2020;174:104677. [PMID: 31836420 DOI: 10.1016/j.antiviral.2019.104677] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
61 Bhandari G, Tiwari V, Gupta A, Jain S, Gupta P, Bhargava V, Malik M, Gupta A, Bhalla AK, Rana DS. CMV presenting as a skin growth in renal transplant patient. Transpl Infect Dis 2021;23:e13590. [PMID: 33641219 DOI: 10.1111/tid.13590] [Reference Citation Analysis]
62 Lindemann M, Korth J, Sun M, Xu S, Struve C, Werner K, Dornieden T, Horn PA, Witzke O, Wilde B. The Cytomegalovirus-Specific IL-21 ELISpot Correlates with Allograft Function of Kidney Transplant Recipients. Int J Mol Sci 2018;19:E3945. [PMID: 30544783 DOI: 10.3390/ijms19123945] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
63 Gozzi-Silva SC, Benard G, Alberca RW, Yendo TM, Teixeira FME, Oliveira LM, Beserra DR, Pietrobon AJ, Oliveira EA, Branco ACCC, Andrade MMS, Fernandes IG, Pereira NZ, Ramos YÁL, Lima JC, Provenci B, Mangini S, Duarte AJDS, Sato MN. SARS-CoV-2 Infection and CMV Dissemination in Transplant Recipients as a Treatment for Chagas Cardiomyopathy: A Case Report. Trop Med Infect Dis 2021;6:22. [PMID: 33579042 DOI: 10.3390/tropicalmed6010022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
64 Choi H, Lee W, Lee HS, Kong SG, Kim DJ, Lee S, Oh H, Kim YN, Ock S, Kim T, Park MJ, Song W, Rim JH, Lee JH, Jeong S. The risk factors associated with treatment-related mortality in 16,073 kidney transplantation-A nationwide cohort study. PLoS One 2020;15:e0236274. [PMID: 32722695 DOI: 10.1371/journal.pone.0236274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Klasen JM, Peterson CJ, Fourie LL, Boldanova T, Terracciano LM, Holbro A, Kollmar O. Small crystals with severe consequences. J Surg Case Rep 2021;2021:rjab135. [PMID: 33927869 DOI: 10.1093/jscr/rjab135] [Reference Citation Analysis]
66 Jaing TH, Chang TY, Chen SH, Wen YC, Yu TJ, Lee CF, Yang CP, Tsay PK. Factors associated with cytomegalovirus infection in children undergoing allogeneic hematopoietic stem-cell transplantation. Medicine (Baltimore) 2019;98:e14172. [PMID: 30681583 DOI: 10.1097/MD.0000000000014172] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
67 Su H, Ye X, Freed DC, Li L, Ku Z, Xiong W, Gao P, Liu X, Montgomery D, Xu W, Espeseth AS, Wang D, Ma N, Fu TM, Zhang N, An Z. Potent Bispecific Neutralizing Antibody Targeting Glycoprotein B and the gH/gL/pUL128/130/131 Complex of Human Cytomegalovirus. Antimicrob Agents Chemother 2021;65:e02422-20. [PMID: 33361306 DOI: 10.1128/AAC.02422-20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Dooley AL, O'Connor CM. Regulation of the MIE Locus During HCMV Latency and Reactivation. Pathogens 2020;9:E869. [PMID: 33113934 DOI: 10.3390/pathogens9110869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
69 Duygu B, Olieslagers TI, Groeneweg M, Voorter CEM, Wieten L. HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation. Front Immunol 2021;12:680480. [PMID: 34295330 DOI: 10.3389/fimmu.2021.680480] [Reference Citation Analysis]
70 Dangi A, Zhang L, Zhang X, Luo X. Murine CMV induces type 1 IFN that impairs differentiation of MDSCs critical for transplantation tolerance. Blood Adv 2018;2:669-80. [PMID: 29563123 DOI: 10.1182/bloodadvances.2017012187] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
71 Bak S, Tischer S, Dragon A, Ravens S, Pape L, Koenecke C, Oelke M, Blasczyk R, Maecker-Kolhoff B, Eiz-Vesper B. Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression. Front Immunol 2018;9:2953. [PMID: 30619313 DOI: 10.3389/fimmu.2018.02953] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
72 Forte E, Zhang Z, Thorp EB, Hummel M. Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response. Front Cell Infect Microbiol. 2020;10:130. [PMID: 32296651 DOI: 10.3389/fcimb.2020.00130] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
73 Hunt J, Chapple KM, Nasar A, Cherrier L, Walia R. Efficacy of low-dose valganciclovir in CMV R+ lung transplant recipients: a retrospective comparative analysis. Multidiscip Respir Med 2021;16:706. [PMID: 33569173 DOI: 10.4081/mrm.2021.706] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
74 Grossi PA, Baldanti F, Andreoni M, Perno CF. CMV infection management in transplant patients in Italy. J Clin Virol 2020;123:104211. [PMID: 31879243 DOI: 10.1016/j.jcv.2019.104211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Noroozi-aghideh A, Kheirandish M. Human cord blood-derived viral pathogens as the potential threats to the hematopoietic stem cell transplantation safety: A mini review. World J Stem Cells 2019; 11(2): 73-83 [PMID: 30842806 DOI: 10.4252/wjsc.v11.i2.73] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
76 de Melo Silva J, Pinheiro-Silva R, Dhyani A, Pontes GS. Cytomegalovirus and Epstein-Barr Infections: Prevalence and Impact on Patients with Hematological Diseases. Biomed Res Int 2020;2020:1627824. [PMID: 33163531 DOI: 10.1155/2020/1627824] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
77 Luo B, Deng C, Hou T, Xu F, Liao Q, Li Y, Wang J. Colon perforation due to cytomegalovirus infection in a patient with idiopathic hypereosinophilic syndrome: a case report. BMC Gastroenterol 2020;20:238. [PMID: 32703162 DOI: 10.1186/s12876-020-01381-1] [Reference Citation Analysis]
78 Monaghan M, Munger J. Contributions of the Human Cytomegalovirus UL30-Associated Open Reading Frames to Infection. J Virol 2021;95:e02417-20. [PMID: 33568511 DOI: 10.1128/JVI.02417-20] [Reference Citation Analysis]
79 El Haddad L, Ariza-Heredia E, Shah DP, Jiang Y, Blanchard T, Ghantoji SS, El Chaer F, El-Haddad D, Prayag A, Nesher L, Rezvani K, Shpall E, Chemaly RF. The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients. J Infect Dis 2019;219:898-907. [PMID: 30295846 DOI: 10.1093/infdis/jiy592] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
80 Solidoro P, Patrucco F, Libertucci D, Verri G, Sidoti F, Curtoni A, Boffini M, Simonato E, Rinaldi M, Cavallo R, Costa C. Tailored combined cytomegalovirus management in lung transplantation: a retrospective analysis. Ther Adv Respir Dis 2019;13:1753466619878555. [PMID: 31566097 DOI: 10.1177/1753466619878555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
81 Jorgenson MR, Descourouez JL, Wong C, Strayer JR, Parajuli S, Rice JP, Redfield RR, Smith JA, Mandelbrot DA, Saddler CM. Cytomegalovirus antiviral stewardship in the COVID-19 Era: Increasing complexity of prophylaxis and treatment and potential mitigation strategies. Transpl Infect Dis 2021;:e13586. [PMID: 33595158 DOI: 10.1111/tid.13586] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Speck NE, Probst-Müller E, Haile SR, Benden C, Kohler M, Huber LC, Robinson CA. Bronchoalveolar lavage cytokines are of minor value to diagnose complications following lung transplantation. Cytokine 2020;125:154794. [PMID: 31400641 DOI: 10.1016/j.cyto.2019.154794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Wahl A, De C, Abad Fernandez M, Lenarcic EM, Xu Y, Cockrell AS, Cleary RA, Johnson CE, Schramm NJ, Rank LM, Newsome IG, Vincent HA, Sanders W, Aguilera-Sandoval CR, Boone A, Hildebrand WH, Dayton PA, Baric RS, Pickles RJ, Braunstein M, Moorman NJ, Goonetilleke N, Victor Garcia J. Precision mouse models with expanded tropism for human pathogens. Nat Biotechnol 2019;37:1163-73. [PMID: 31451733 DOI: 10.1038/s41587-019-0225-9] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 16.7] [Reference Citation Analysis]
84 Hawthorne TZ, Shellien R, Chambers L, Devereux G. CMV pneumonitis in a patient with Crohn's disease taking azathioprine. BMJ Case Rep 2021;14:e241256. [PMID: 33893128 DOI: 10.1136/bcr-2020-241256] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Li KHC, Ho JCS, Recaldin B, Gong M, Ho J, Li G, Liu T, Wu WKK, Wong MCS, Xia Y, Dong M, Tse G; International Health Informatics Study Network. Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis. Transplant Proc 2018;50:3723-31. [PMID: 30577263 DOI: 10.1016/j.transproceed.2018.08.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
86 Idossa DW, Simonetto DA. Infectious Complications and Malignancies Arising After Liver Transplantation. Anesthesiol Clin 2017;35:381-93. [PMID: 28784215 DOI: 10.1016/j.anclin.2017.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
87 Gugliesi F, Coscia A, Griffante G, Galitska G, Pasquero S, Albano C, Biolatti M. Where do we Stand after Decades of Studying Human Cytomegalovirus? Microorganisms 2020;8:E685. [PMID: 32397070 DOI: 10.3390/microorganisms8050685] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
88 Cristelli MP, Esmeraldo RM, Pinto CM, Sandes-freitas TV, Felipe C, Lobo CF, Viana L, Mansur J, Stopa S, Santos DWC, Grenzi PC, Aguiar WF, Tedesco-silva H, Pestana JOM. The influence of mTOR inhibitors on the incidence of CMV infection in high-risk donor positive-recipient negative (D+/R−) kidney transplant recipients. Transpl Infect Dis 2018;20:e12907. [DOI: 10.1111/tid.12907] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
89 Wang NL, Li LT, Wu BB, Gong JY, Abuduxikuer K, Li G, Wang JS. The Features of GGT in Patients with ATP8B1 or ABCB11 Deficiency Improve the Diagnostic Efficiency. PLoS One 2016;11:e0153114. [PMID: 27050426 DOI: 10.1371/journal.pone.0153114] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]